摘要
目的:探讨行为心理医学对2型糖尿病患者规范化诊治的作用,以期提高患者血糖控制效果及生活质量.方法:选取 60 例 2021 年 6 月至 2022 年 6 月郑州市第一人民医院航东社区卫生服务中心的 2 型糖尿病患者作为研究对象,采用数字随机表法分为观察组与对照组,各 30 例.对照组患者给予降糖药物治疗,观察组患者在对照组治疗基础上进行行为心理医学干预,比较两组患者的治疗依从性、治疗前、治疗1 年后代谢指标[空腹血糖(FPG)、餐后2 h血糖(2h PG)、糖化血红蛋白(HbA1c)、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)]、生活质量及不良事件发生率(低血糖、因急诊就诊、并发症住院、严重低血糖住院).结果:观察组患者治疗依从性为 86.67%,高于对照组的 56.67%,差异具有统计学意义(P＜0.05);观察组患者治疗后FPG、2h PG、HbA1c、TG、TC、LDL-C水平较对照组低,差异具有统计学意义(P＜0.05);观察组患者治疗后各项生活质量(躯体功能、社会功能、心理健康、活力、情感角色、整体健康)评分较对照组高,差异具有统计学意义(P＜0.05);观察组患者不良反应发生率为16.67%,低于对照组的40.00%,差异具有统计学意义(P＜0.05).结论:行为心理医学可促进2型糖尿病患者治疗依从性、机体代谢指标改善,有利于减少不良事件发生,提高生活质量,改善预后.
Abstract
Objective To explore the role of behavioral and psychological medicine in the standardized diagnosis and treatment of type 2 diabetes mellitus,in order to improve the effect of blood glucose control and the quality of life in patients.Methods A total of 60 patients with type 2 diabetes mellitus from Zhengzhou First People's Hospital Hangdong Community Health Service Center from June 2021 to June 2022 were selected as the research subjects and randomly divided into an observation group and a control group,with 30 cases in each group.The control group was given hypoglycemic drug treatment,while the observation group received behavioral and psychological medical intervention in addition to the treatment given to the control group.The treatment compliance,metabolic indicators[fasting plasma glucose(FPG),2-hour postprandial glucose(2hPG),glycated hemoglobin(HbA1c),triacylglycerol(TG),total cholesterol(TC),low density lipoprotein chesterol(LDL-C)]before and after 1 year of treatment,quality of life,and the incidence of adverse events(hypoglycemia,emergency visits,hospitalization due to complications,severe hypoglycemia)were compared between the two groups.Results The treatment compliance rate in the observation group was 86.67%,which was higher than 56.67%in the control group,with a statistically significant difference(P＜0.05).The levels of FPG,2hPG,HbA1c,TG,TC,and LDL-C after treatment in the observation group were lower than those in the control group,with statistically significant differences(P＜0.05).The quality of life scores(physical function,social function,mental health,vitality,emotional role,overall health)after treatment in the observation group were higher than those in the control group,with statistically significant differences(P＜0.05).The incidence of adverse reactions in the observation group was 16.67%,which was lower than 40.00%in the control group,with a statistically significant difference(P＜0.05).Conclusion Behavioral and psychological medicine can promote treatment compliance and improve metabolic indicators in patients with type 2 diabetes mellitus,which is beneficial for reducing the occurrence of adverse events,improving the quality of life,and enhancing prognosis.
基金项目
河南省医学科技攻关计划(联合共建)项目(LHGJ20210713)
NETL
NSTL
万方数据